ArticleMedical oncology (Northwood, London, England)2025

Identification of Isovitexin as a novel CYP17A1 inhibitor through virtual screening and evaluation of its anti-cancer effects in MCF-7 breast cancer cells.

Lathika Shanmugam et al.PubMed ↗Publisher ↗

No numbers read from the abstract.